argyrotsipi/train-dataset huggingface dataset:
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Diane Julie Abbott (Labour, Centre-left): It is shameful that we saw those scenes at Southend airport, and that families continue to suffer because the arrangements are so slow. It is, however, appropriate that we are discussing this issue on the day on which my hon. Friend the new Member for Newport West (Ruth Jones) has taken her seat, because her predecessor, my friend Paul Flynn, was an indefatigable campaigner for many important causes, including the legalisation of cannabis for medical use Last year Charlotte Caldwell, the mother of another sick child, Billy Caldwell, said: "It’s absolutely incredible, it’s amazing. The compassion and speed that the Home Secretary has moved with is just incredible." That is the impression that Ministers sought to give, but it was a misleading impression, as the plight of the Applebys revealed this weekend Is the Secretary of State aware that cannabis oil is not the same as cannabis, and that it has no psychoactive or addictive effects? Is he aware that in other jurisdictions a range of conditions qualify for treatment with cannabis oil and related products, including cancer, AIDS, muscular dystrophy, Crohn’s disease, epilepsy, Parkinson’s disease and arthritis? Is he aware that the Home Secretary has previously commissioned Sally Davies to examine the scheduling of cannabis as a whole? She reported as long ago as June 2018. Is the Secretary of State aware that Ms Davies’s report has been with the Advisory Council on the Misuse of Drugs since that time? Is the House to understand that the Home Secretary has just been sitting on it What is the Secretary of State going to do to speed up the processes around this issue? Parents will not be impressed to hear of further reports or further enquiries. We need to resolve the Appleby case quickly, but we also need to make sure that no other families of sick children have to suffer in the way the Appleby family is suffering.
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Benjamin Peter James Bradshaw (Labour, Centre-left): The Secretary of State talks about removing barriers, but it is clear to me that the main barrier is the British Paediatric Neurology Association itself. When its president came to give evidence to the Health and Social Care Committee a couple of weeks ago, he was arrogant, he was dismissive of the families’ experience, and he misled our Committee by denying that Members of this House had sought a dialogue with him, which he had refused. What is the Secretary of State going to do to remove the obstacle of the BPNA?
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Thangam Elizabeth Rachel Debbonaire (Labour, Centre-left): I am grateful to the Secretary of State for what he has said so far, but I have spoken with a neurosurgeon in my constituency who says that one of his anxieties is not being able to give good advice to parents whom he suspects might be trying to access medical cannabis through not wholly legal routes, because he is unsure what the law is. I agree with the Secretary of State on the need for clinical evidence, so what more information can he give us on the timescale? When will we see the health education research that he talks about? In the meantime, why can we not use the evidence of clinical trials conducted elsewhere?
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Antonia Louise Antoniazzi (Labour, Centre-left): I congratulate the right hon. Member for Hemel Hempstead (Sir Mike Penning), my co-chair of the APPG on medical cannabis under prescription. The situation is, frankly, intolerable. I have spoken with all of the families requesting medicinal cannabis with THC—let us not forget the THC. I am sure that Teagan will get a second opinion and that she is another child who will get access to medical cannabis, but what about all the others? They cannot wait. My right hon. Friend the Member for Exeter (Mr Bradshaw) spoke truthfully about the inquiry and the evidence it has taken. The BPNA has not spoken as it should have and it has not done enough to support the families.
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Antonia Louise Antoniazzi (Labour, Centre-left): I will not use that word, but I totally agree with my right hon. Friend. I say to the Secretary of State that this has got to stop. We cannot wait for clinical trials. There is medicine out there—get it to the children who need it.
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Stephen Twigg (Labour, Centre-left): I have previously raised the case of my constituent, 11-month-old Nathaniel Leahy, who, owing to his extremely rare form of epilepsy, lives in great pain. His mum told me today: "I am living in fear each day that Nathaniel will not make it to the next day. We were promised in November of last year that this medicine would be available." Does the Secretary of State understand the powerful sense of frustration felt by families such as Nathaniel’s, and will he address the question of the guidelines so that we can have fewer stringent guidelines, to benefit patients?
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Paula Michelle Sherriff (Labour, Centre-left): It has always been the case that the Home Secretary could issue a special licence to allow the medical use of cannabis oil. I understand that the Health Secretary may be seeing him this evening, and I wondered whether he will ask him to consider this course of action.
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Diana Ruth Johnson (Labour, Centre-left): It was clear from the evidence given to the Health and Social Care Committee that the Government raised public expectations when they rescheduled medical cannabis. I wonder whether it is time for the Secretary of State to ensure that there is a public awareness campaign, with full information about what the Government are trying to do.
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Alexander James Jorden Norris (Labour, Centre-left): Like many colleagues, I have spoken with parents of children who have profound challenges that could be ameliorated by medicinal cannabis. They are at their wits’ end, and it is no surprise to find that some in this country resort to desperate measures. I have listened for 45 minutes now and I cannot tell the answer to this question: is the Secretary of State really saying that we have a clear, universal, safe and compassionate approach to this issue and, if we do not, when will we?
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Mary Theresa Glindon (Labour, Centre-left): Lara Smith, my constituent, is really upset about what happened to Teagan and her family at the weekend. Lara travels to Holland every three months to get a schedule 2 drug, Bedrocan, for her seriously debilitating illness. It could be imported but, if it was, unfortunately, she would have to bear the licence fee. Will the Minister say whether anything can be done for her?
Access to Medical Cannabis — House of Commons, 2019-04-08
Topic: Health
Jeffrey Smith (Labour, Centre-left): I agree that we need to remove the barriers for clinicians. We need evidence, but the problem with randomised control trials is the nature of cannabis. The fact that it contains many different compounds that interact makes it difficult to isolate the compounds that work for individuals. Cannabis is a unique treatment, and should really be in a licensing and scheduling category of its own to allow different approaches. I urge the Secretary of State to encourage observational trials so that we can allow patients to get access to the medical cannabis that will work for them.
Online Harms White Paper — House of Commons, 2019-04-08
Topic: Health
David Lindon Lammy (Labour, Centre-left): Forty or 50 years ago, the tobacco industry was largely responsible for driving up cancer in our country. It took the Department of Health many years to start to regulate what was going on in the industry and deal with it on behalf of the taxpayer. It is clear from looking at some drill music and its relationship with knife crime and gang culture, and self-harm among young people, that mental ill health is being driven by much of this social media. Will the Secretary of State say something about the intersection between the Department of Health and Social Care, the chief medical officer and the new regulator?
Online Harms White Paper — House of Commons, 2019-04-08
Topic: Health
Mary Elizabeth Twist (Labour, Centre-left): As chair of the all-party group on suicide and self-harm prevention, I welcome today’s online harms paper as a significant step towards protecting the most vulnerable young people, but the proof will be in the implementation, and a major challenge is that much of the damaging content is hosted outside the UK. What will the Government be doing to scale up their plans and to drive forward global change to protect young vulnerable people?
Online Harms White Paper — House of Commons, 2019-04-08
Topic: Health
Emma Ann Hardy (Labour, Centre-left): The Secretary of State might be aware that I have been meeting the Minister for suicide prevention, the Under-Secretary of State for Health and Social Care, the hon. Member for Thurrock (Jackie Doyle-Price), to discuss my deep concern and upset over the rising number of suicides in my constituency. Just last week, there were thousands of posts under the hashtag "suicide" on Instagram. What can the White Paper do to address that?
Online Harms White Paper — House of Commons, 2019-04-08
Topic: Health
Christopher Philip James Elmore (Labour, Centre-left): I welcome the Secretary of State’s paper; I would argue that it is long overdue. He may be aware that last week, and three weeks ago, I launched a report by the all-party parliamentary group on social media and young people’s mental health and wellbeing. The report was about social media and its impact on young people. Many of its recommendations are in the White Paper, and I genuinely welcome that. One that is not is a 0.5% levy on social media companies’ profits, which could go into a social media health alliance. One thing that we heard during our inquiry from clinicians and young people was that we needed far more research into the impact of social media on mental health. Many individual areas of research need to be collated so that we can educate, inform and protect our young people as technology advances.
Leaving the EU: Health Services and Legal Action — House of Commons, 2019-03-14
Topic: Health
Questions: What steps the Government are taking to prevent potential legal action by companies overseas in relation to the provision of health services in any future trade deals after the UK leaves the EU.
David Drew (Labour, Centre-left): What guarantees can the Secretary of State give us that pharmaceutical companies will not relocate to the EU, meaning that in effect more and more of our drugs would be imported? Will he give a guarantee that that will not happen?
Export Licences: High Court Judgment — House of Commons, 2019-06-20
Topic: Defense
Diana Ruth Johnson (Labour, Centre-left): The Secretary of State has referred to the European common position several times. What is his assessment of the European countries that have decided to suspend arms exports to Saudi Arabia? Why does he disagree with their position?
Export Licences: High Court Judgment — House of Commons, 2019-06-20
Topic: Defense
Lloyd Russell-Moyle (Labour, Centre-left): I have just returned from the Court of Appeal, where I listened to the judgment. The judges, in paragraph 141, say there was a decision in 2016 no longer to apply criterion 2 on the checking of IHL. This resulted in 100,000 deaths. Who made that decision My Committees, the Committees on Arms Export Controls, have manifestly failed to hold the Government to account. We now need urgent reform of the Committees’ powers, including creating a standalone Committee. Will the Minister confirm that he will not allow the use of any existing open licences to coalition partners during this review Finally, after the arms scandals of the 1980s and ’90s we had the Scott inquiry, and we now need an independent judge-led or parliamentary inquiry not just on this particular issue but on the failings of our arms control system—taking it away from the political interference and political control of Ministers to a truly independent and world-class system, which we do not have at the moment.
Export Licences: High Court Judgment — House of Commons, 2019-06-20
Topic: Defense
Ruth Margaret Cadbury (Labour, Centre-left): The UK’s significant levels of arms production and exports is often justified by the need to protect jobs, and today we have been told that there is a risk of terrorism if we do not export arms to this appalling regime. Rather than being complicit in killing almost 100,000 Yemenis, if the Government really want to protect jobs, reduce the risk of terrorism and enhance the UK’s reputation around the world, why not stop Brexit?
Engagements — House of Commons, 2019-05-15
Topic: Health
Questions: The Prime Minister has often spoken about how important it is to ensure that everyone gets a fair chance in life, which of course include carers. Will she therefore join me in welcoming the award given to Annette Collier at Friday’s Pride of Rugby awards, run by our fabulous local radio station? Annette is a leader for Rugby Young Carers, and her great dedication, inspiration and enthusiasm is helping youngsters in my constituency to live their own lives.
Jeremy Bernard Corbyn (Labour, Centre-left): I join the Prime Minister in acknowledging Mental Health Awareness Week. I want to send my support to all those campaigning all across the country to raise awareness of mental health, and a message that all of us can do something about it by reaching out and talking to people going through a mental health crisis, and also ensuring that there is proper funding for our mental health services I would like to pay tribute to the former Labour MP for Birmingham, All Saints, Brian Walden, who passed away this week. He was a very formidable figure in this House and a very strong political interviewer who every politician really loved being interviewed by at the time—but they only said that afterwards I think it would also be only right that the House of Commons pays tribute to a leading Hollywood icon and campaigner for animal welfare, Doris Day, who passed away this week. I am tempted to quote some Doris Day songs, but I won’t. [Interruption.] All right—"Whip-Crack-Away!" [Interruption.] No, no, no. [Interruption.] I do apologise, Mr Speaker—I have obviously started a parliamentary singalong here Speaking of icons, it would be right to acknowledge that it is 40 years since my hon. Friend the Member for Huddersfield (Mr Sheerman) and my right hon. Friend the Member for Birkenhead (Frank Field) were both elected to this Parliament for the first time in the 1979 election In the last two years, nine of the UK’s richest hedge fund tycoons have donated £2.9 million to the Conservative party. Is this a Government for the many or one in the pockets of an elite few?
Learning Disabilities Mortality Review — House of Commons, 2019-05-15
Topic: Health
Barbara Mary Keeley (Labour, Centre-left): Well, this is a mess, isn’t it? Last year, the first report from this important review was sneaked out on a Friday, in the middle of the local election results, and this year we have read about it through leaks to The Sunday Times and the Health Service Journal. The Minister says that it is a draft that is going to be published shortly; I understand that the authors handed it over on 1 March. How long does it take the Department to turn round a draft? Clearly, somebody somewhere thinks it should be out there, because somebody somewhere is leaking it. Will the Minister take responsibility for this process and ensure that future reports are published in a timely manner? I am not happy with "shortly" or "in a few weeks"; will she tell us when the full copy of the report—not just what was leaked, first in the Sunday papers and now in the Health Service Journal—will be available It appears from the leak that the review has been able to consider only a quarter of the premature deaths reported to it, leaving more than 3,000 families waiting for closure—it is those 3,000 families on whom we should be focusing—and that well over a third of cases do not even have a reviewer assigned to them. That shows that, as we suspected last year, the LeDeR programme is significantly under-resourced, so will the Minister pledge now to ensure that the review has the resources it needs in future Last year, the Government made 24 specific commitments relating to the annual report, and 15 of them were due to be completed by now. Will the Minister update the House on the progress on those commitments The leak tells us that the review found that in 8% of cases the care given "fell so short of good practice that it significantly impacted on their wellbeing or directly contributed to their cause of death" What is the Minister doing now to ensure that no more people with learning disabilities die early because of poor care? Lastly, and most disgracefully—I am certainly going to mention this from the leaked report—the report says that over a period of two years, at least 19 people with learning disabilities who died had "learning disabilities" or "Down’s syndrome" given as the reason not to resuscitate them. A patient having a learning disability or Down’s syndrome is not a reason to put a "do not resuscitate" order on their care. Does the Minister agree that such an approach, if it exists, smacks of eugenics and is completely unacceptable? What action will she take to ensure that it does not continue?
Learning Disabilities Mortality Review — House of Commons, 2019-05-15
Topic: Health
Diana Ruth Johnson (Labour, Centre-left): I wonder if the Minister recognises that for many families the review feels like the NHS marking its own homework, and that there needs to be more of an independent body to look at all the cases to give the reassurance that those families want.
Serious Violence — House of Commons, 2019-05-15
Topic: Health
Victoria Jane Foxcroft (Labour, Centre-left): It appears that the Home Secretary may be leaving this debate while the hon. Gentleman is making an extremely important contribution on the public health approach. Does he agree that that is a very disappointing thing to see?
Serious Violence — House of Commons, 2019-05-15
Topic: Health
Stephen John Doughty (Labour, Centre-left): I wholeheartedly agree with what the hon. Gentleman is saying about the public health approach. Does he agree that there is a lot to be learned from the devolved Administrations? In Wales, there is excellent partnership working between South Wales police and our local health boards on a series of issues relating to violence—not only violence in our cities at night but domestic violence, with thousands of women now being protected as a result of partnership working between the health boards and policing.
British Steel — House of Commons, 2019-05-22
Topic: Defense
Nicholas Desmond John Smith (Labour, Centre-left): The Government need to buy more UK-produced steel, yet the Ministry of Defence has refused to confirm that it will buy UK steel for the Navy’s solid support ships. Less than half of the steel currently bought by the Government is from the UK. How high will that percentage be in a year’s time to help avoid recurring steel crises?
British Steel — House of Commons, 2019-05-22
Topic: Defense
James Dolan Cunningham (Labour, Centre-left): We have been here on two or three occasions, including with GKN and Bombardier, so one wonders where we are going, as the steel industry is vital to manufacturing in this country and, more importantly, to the defence industry. I thank the Secretary of State for his statement, but I can tell him that I worked at Rolls-Royce when it collapsed in 1971 and there is no worse situation an employee can find themselves in; that situation went on for weeks, until eventually the Heath Government had to semi-nationalise it. I have the feeling that you may be back here in a couple of weeks’ time if you cannot find a buyer, so you will really have to consider that. I hope you will consider that, because if you do not, you will be inflicting a lot of pain on a lot of good employees who work very hard. Once you have experienced something like that, you never forget it.
No Deal: NHS — House of Commons, 2019-06-27
Topic: Health
Questions: What discussions he has had with the Secretary of State for Health and Social and Care on the effect on the NHS of the UK leaving the EU without a withdrawal agreement.
Mary Elizabeth Twist (Labour, Centre-left): Before March, the NHS was stockpiling medical supplies, including body bags, medicines and blood. Many people with long-term conditions fear that essential drugs or specialist food supplies such as those for people with PKU—phenylketonuria—will not be available. What discussions is the Secretary of State having with the Secretary of State for Health and Social Care to ensure that medicines and other medical supplies are consistently available, on time, for people who need them?
No Deal: NHS — House of Commons, 2019-06-27
Topic: Health
Questions: What discussions he has had with the Secretary of State for Health and Social and Care on the effect on the NHS of the UK leaving the EU without a withdrawal agreement.
Barry John Sheerman (Labour, Centre-left): May I remind the Secretary of State that this is not just about medicines, although that is important enough, but also about staff? Is he aware of how many distressed loyal servants of the NHS have now decided that this is a hostile environment in our country and are going home to their own European countries? That is very sad. Will he remind the contenders to be our next Prime Minister that they do not have a majority in the House of Commons and when they get back here they are going to get a short shower of reality on them?
No Deal: Pharmaceutical Products — House of Commons, 2019-06-27
Topic: Health
Questions: What recent assessment he has made of the adequacy of the security of supply for pharmaceutical products in the event that the UK leaves the EU without a deal.
Adrian Edward Bailey (Labour, Centre-left): A no-deal Brexit would see the UK lose access to the falsified medicines directive, which prevents substandard and counterfeit medicines from entering our market. The head of the Healthcare Distribution Association has said that, as a result, the UK would be "less safe". What steps has the Minister taken to prevent that?
Northern Ireland (Executive Formation) Bill — House of Commons, 2019-07-09
Topic: Health
Owen Smith (Labour, Centre-left): Does the right hon. Gentleman not accept that there have been instances in the recent past when we have legislated in this place on what has ostensibly been a devolved competence? I am thinking of, for example, the provision to extend access to medicinal cannabis to Northern Ireland.
Points of Order — House of Commons, 2019-03-21
Topic: Health
Victoria Jane Foxcroft (Labour, Centre-left): On a point of order, Mr Speaker. I seek your advice. The Government are supposed to be tackling violence with a public health approach, so I was astonished when my question to the Secretary of State for Health and Social Care asking what progress his Department has made on the implementation of a public health approach to tackling violence was transferred to the Home Office for a written response. My question was genuinely meant for the Secretary of State for Health and Social Care, as I am keen to know whether he endorses a public health approach and what action his Department is taking. The public health approach can be successful only if it is genuinely adopted across the whole of Government.